Quarterly report pursuant to Section 13 or 15(d)

Benefit Plans (Tables)

v3.23.1
Benefit Plans (Tables)
 3 Months Ended
Mar. 31, 2023
Retirement Benefits [Abstract]  
Schedule of Fair Value of Options Granted
The following table summarizes the weighted-average assumptions used to compute the fair value of options granted to employees, members of our board of directors and non-employees:

  For the Three Months Ended March 31,
  2023 2022
Risk-free interest rate 4.0% 1.4%
Expected life of options — years 3.80 3.60
Expected stock price volatility 31% 32%
Expected dividend yield 1.9% 1.3%
Schedule of Stock Options Activity Under Share-based Payment Plans
The following table summarizes stock option activity under our share-based plans for the three months ended March 31, 2023:
  Options Weighted-Average
Exercise Price
Per Share		 Weighted-Average
Remaining
Contractual Term (Years)		 Aggregate
Intrinsic
Value
Outstanding as of December 31, 2022 134  $ 5.55 
Granted 9  $ 4.99 
Exercised (1) $ 3.74 
Forfeited, cancelled or expired (1) $ 5.73 
Outstanding as of March 31, 2023 141  $ 5.52  5.30 $ 10 
Exercisable as of March 31, 2023 95  $ 5.36  4.52 $ 10 
Schedule of Restricted Stock Unit and Stock Award Activity
The following table summarizes the restricted stock unit, including PRSU, activity under our share-based plans for the three months ended March 31, 2023:
  Shares Grant Date
Fair Value Per Share
Nonvested as of December 31, 2022 85  $ 6.38 
Granted 8  $ 4.76 
Vested (6) $ 6.82 
Forfeited (6) $ 6.31 
Nonvested as of March 31, 2023 81  $ 6.22